Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sotera Health (SHC) EBITDA (2020 - 2025)

Historic EBITDA for Sotera Health (SHC) over the last 6 years, with Q3 2025 value amounting to $31.2 million.

  • Sotera Health's EBITDA fell 1745.82% to $31.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.5 million, marking a year-over-year decrease of 952.27%. This contributed to the annual value of -$71.2 million for FY2024, which is 20891.24% down from last year.
  • Sotera Health's EBITDA amounted to $31.2 million in Q3 2025, which was down 1745.82% from $89.1 million recorded in Q2 2025.
  • Over the past 5 years, Sotera Health's EBITDA peaked at $89.1 million during Q2 2025, and registered a low of -$262.4 million during Q4 2022.
  • Its 5-year average for EBITDA is -$470684.2, with a median of $5.5 million in 2025.
  • In the last 5 years, Sotera Health's EBITDA crashed by 315932.69% in 2022 and then surged by 63092.87% in 2025.
  • Quarter analysis of 5 years shows Sotera Health's EBITDA stood at $58.4 million in 2021, then crashed by 549.4% to -$262.4 million in 2022, then skyrocketed by 122.92% to $60.1 million in 2023, then crashed by 218.57% to -$71.3 million in 2024, then surged by 143.73% to $31.2 million in 2025.
  • Its EBITDA stands at $31.2 million for Q3 2025, versus $89.1 million for Q2 2025 and $5.5 million for Q1 2025.